Lung Tumor Clinical Trial
Official title:
GLUT1: A Novel Tool Reflecting Proliferative Activity of Lung Neuroendocrine Tumors
Lung neuroendocrine tumor (LNT) represents approximately 20% of all lung cancers. The
classification of LNT relies upon morphology. Recently, in the World Health Organization
(WHO) classification, Ki-67 rate has been proposed for classi fication. It is, however, known
that Ki-67 count has a poor interlaboratory reproducibly. For that reason, our team has
looked for a new biomarker.
GLUT1 protein a facilitative glucose transporter protein which has ubiquitous expression in
mammalian. GLUT1 is overexpressed in many human cancers. But, no study has evaluated the
GLUT1 staining as an aid diagnosis in LNT.
The team have assessed the GLUT1 immunohistochemical staining in 36 LNT and to assess its
diagnostic value.
The (LNT) Lung neuroendocrine tumor represents approximately 20% of all lung cancers. The
classification of LNT relies upon morphology. Recently, in the World Health Organization
(WHO) classification, Ki-67 rate has been proposed for classi fication. It is, however, known
that Ki-67 count has a poor interlaboratory reproducibly. For that reason, our team has
looked for a new biomarker.
GLUT1 protein a facilitative glucose transporter protein which has ubiquitous expression in
mammalian. GLUT1 is overexpressed in many human cancers. But, no study has evaluated the
GLUT1 staining as an aid diagnosis in LNT.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02939729 -
Physiotherapy Prehabilitation in Patients Undergoing Cardiac or Thoracic Surgery
|
N/A | |
Completed |
NCT02559349 -
Gut Microbiota And Radiotherapy
|
||
Completed |
NCT02862288 -
Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.
|
Phase 1/Phase 2 | |
Recruiting |
NCT04056273 -
Assess the Use of rEBUS With a Guide Sheath to Increase Transbronchial Lung Biopsy Yield Rate
|
N/A | |
Recruiting |
NCT03528733 -
Feasibility of Multi-Energy Digital Radiography Detector for Lung Lesions Detection
|
N/A | |
Completed |
NCT03972228 -
Microdevice for Evaluating Drug Response in Site in Lung Lesions
|
Early Phase 1 | |
Not yet recruiting |
NCT06397807 -
Postoperative Pain Management on Patients Undergoing Lung Tumor Resection
|
||
Withdrawn |
NCT04917224 -
Study of LUNG Stereotactic Adaptive Ablative Radiotherapy
|
N/A | |
Active, not recruiting |
NCT03881410 -
The Efficacy of Shear-wave Elastography-guided Aspiration and Biopsy for Diagnosis in Lung Tumor
|
N/A | |
Not yet recruiting |
NCT05279521 -
The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer.
|
N/A | |
Recruiting |
NCT06322329 -
RealMove (Lung): Assessing Tumour Motion With Dynamic MRI
|
N/A | |
Active, not recruiting |
NCT05169437 -
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
|
Phase 2 | |
Completed |
NCT01394978 -
NeoMend ProGELâ„¢ Pleural Air Leak Sealant Post-Approval Study
|
N/A | |
Recruiting |
NCT04974632 -
Mobile 3D C-arm CT for Lung Tumor Localization Efficacy Analysis: a Prospective Clinical Trial
|
N/A | |
Active, not recruiting |
NCT05555342 -
A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm
|
Early Phase 1 | |
Completed |
NCT01388803 -
The Depth of Right Bronchial Blocker Placement in Taiwanese in Video-assisted Thoracoscopic Surgery(VATS)
|
N/A | |
Recruiting |
NCT04075305 -
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
|